Top compounds associated with response to RP11-219A15.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.015 0.6
mRNA STF-31 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA pluripotin CTRPv2 pan-cancer AAC 0.017 0.6
mRNA GSK4112 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.015 0.6
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.017 0.6
Download CSV